Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03735017 · ClinicalTrials.gov registry record · NA
Virtual Reality Walking for Neuropathic Pain in Spinal Cord Injury
A NA study of Spinal Cord Injuries and Neuropathic Pain, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT03735017: Completed NA study of Spinal Cord Injuries and Neuropathic Pain, sponsored by University of Alabama at Birmingham.
NCT03735017 is a NA study of Spinal Cord Injuries and Neuropathic Pain that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 27 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03735017, a NA study of Spinal Cord Injuries and Neuropathic Pain, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the effectiveness of one of two virtual reality treatments on neuropathic pain in individuals with spinal cord injury.
Primary Outcome
The Numeric Rating Scale (NRS) measures pain intensity measured via 0-10 numeric rating scale. Range of scores: 0-10
Conditions Studied
Interventions
- OTHER Non-Interactive Virtual Reality Walking
- OTHER Interactive Virtual Reality Walking
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-06-16 |
| Est. Completion | 2019-07-30 |
| Phase | NA |
What the finished NCT03735017 record still lists
NCT03735017 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (56% lower).
The record links to 2 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 2 interventions - of which Non-Interactive Virtual Reality Walking is the first listed.
NCT03735017 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT03735017 about?
NCT03735017 is a clinical study titled "Virtual Reality Walking for Neuropathic Pain in Spinal Cord Injury". This study will examine the effectiveness of one of two virtual reality treatments on neuropathic pain in individuals with spinal cord injury.
What is the current status of trial NCT03735017?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2018-06-16. Estimated completion is 2019-07-30.
What conditions does trial NCT03735017 study?
This clinical trial studies the following conditions: Spinal Cord Injuries, Neuropathic Pain.
What interventions are being tested in trial NCT03735017?
The interventions under investigation include: Non-Interactive Virtual Reality Walking (OTHER), Interactive Virtual Reality Walking (OTHER).
Who is sponsoring clinical trial NCT03735017?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03735017 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03735017's enrollment target sits among peer trials
27 105th of 202 higher than 96 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
- NCT03690011 · 27 participants · Phase 1
Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy